Renaissance Technologies’s Sanara MedTech SMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.59M Buy
67,400
+2,720
+4% +$56.2K ﹤0.01% 2095
2026
Q1
$1.11M Buy
64,680
+27,078
+72% +$557K ﹤0.01% 2221
2025
Q4
$878K Sell
37,602
-4,098
-10% -$106K ﹤0.01% 2349
2025
Q3
$1.32M Buy
41,700
+4,300
+11% +$130K ﹤0.01% 2338
2025
Q2
$1.06M Buy
37,400
+3,100
+9% +$93K ﹤0.01% 2489
2025
Q1
$1.06M Sell
34,300
-1,100
-3% -$37.3K ﹤0.01% 2390
2024
Q4
$1.18M Buy
35,400
+21,400
+153% +$726K ﹤0.01% 2402
2024
Q3
$423K Sell
14,000
-100
-0.7% -$3.12K ﹤0.01% 2858
2024
Q2
$398K Sell
14,100
-800
-5% -$25.1K ﹤0.01% 2794
2024
Q1
$551K Buy
14,900
+4,900
+49% +$183K ﹤0.01% 2820
2023
Q4
$411K Buy
10,000
+1,200
+14% +$38.5K ﹤0.01% 2859
2023
Q3
$274K Buy
+8,800
New +$341K ﹤0.01% 2973
2021
Q3
Sell
-7,300
Closed -$270K 3812
2021
Q2
$270K Buy
+7,300
New +$213K ﹤0.01% 3177

Other funds holding SMTI

Renaissance Technologies's SMTI Position: Q2 2026 in Review

Renaissance Technologies increased its Sanara MedTech (SMTI) stake by 4.2% in Q2 2026, buying an estimated $56.2K and bringing the position to 67,400 shares worth $1.59M. The position accounts for ﹤0.01% of the portfolio, ranked #2095.

Renaissance Technologies first reported a position in SMTI in Q2 2021 and has held it in 13 quarters since. 75 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.

  • Renaissance Technologies held 67,400 shares of Sanara MedTech worth $1.59M as of Q2 2026.
  • Renaissance Technologies bought 2,720 Sanara MedTech shares in Q2 2026, an estimated $56.2K.
  • Sanara MedTech made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #2095 holding.
  • Renaissance Technologies first reported a position in Sanara MedTech in Q2 2021 and has held it in 13 quarters since.
  • 75 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.